The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while “artificially” inflating costs for patients. 



1197447255

Reuters

United Kingdom

US FTC sues drug 'gatekeepers' over high insulin prices

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetic patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Woodbridge Company

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients.

Associated Press News

Independent Media

United States

High insulin prices spur a federal lawsuit against three pharmacy benefit managers

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for patients

abc News

The Walt Disney Company

The Federal Trade Commission alleges CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx created a system that prioritizes high rebates from drug manufacturers, leading to artificially high insulin list prices.

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

By Tami Luhby, CNN (CNN) — The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more the medications. The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and United Health Group’s OptumRx and their affiliated group purchasing organizations created a system that prioritizes hig…

KIFI

News-Press & Gazette Company

Idaho Falls

Bonneville County

Idaho

By Tami Luhby, CNN (CNN) — The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more for the medications. The agency alleges that CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s Optum Rx and their affiliated group purchasing organizations created a system that pr…

KRDO

Colorado Springs

El Paso County

Colorado

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.

CNBC

Roberts family

FTC sues drug middlemen for allegedly inflating insulin prices

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while “artificially” inflating the list price of insulin.  The agency’s action targeted CVS Caremark Rx, Cigna’s Express Scripts and UnitedHealth’s OptumRx. The three companies combined administer about 80 percent of all prescriptions…

The Hill

Nexstar Media Group

Washington

District of Columbia

FTC sues three largest drug middlemen for allegedly inflating insulin prices

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts, and UnitedHealth Group Inc’s (NYSE:UNH) Optum—for allegedly engaging in unfair and anti-competitive practices that have inflated the list price of insulin medications. The complaint accuses the PBMs of creating a system that benefits them financia…

Benzinga

New York

US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices - CVS Health (NYSE:CVS), Cigna (NYSE:CI), UnitedHealth Group (NYSE:UNH)

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.

Bloomberg

Michael Bloomberg

The Vanguard Group

Howard Buffett

BlackRock

FTC Sues Drug Middlemen Over Manipulating Insulin Market

Diabetes

UnitedHealth

Cigna

Politics

US Politics

Health

Medical

Washington Top News

NBC News

OC Register

The Oregonian

MarketWatch

Spectrum Local News

Politico

Wall Street Journal

9NEWS Denver

WPRI 12

WFAA 8abc

Financial Times

U.S. News

Morning Sun

WCSH

WBAL

WKYC

WLTX

KEYT

WBIR

KION

Krem2 News

DNyuz

BizToc

Scripps News

Jingletree

KTVB

abc12/WJRT

Straight Arrow News

News Talk 94.1/AM 1600

Fort Smith/Fayetteville News

Fast Company

KYTX

The World Without Fake News!

India Daily Mail

MedPage Today

The Smart Citizen Report

BalkansTimes

Stockxpo - A professional network of traders, investors and analysts

Law360

The News God

The Business Journal

New Orleans CityBusiness

thealbertan.com

wng.org

news247planet.com

Verve times

Endpoints News

Pharmacy Times

ajmc.com

healthcaredive.com

Good Word News

Market Research Telecast

globalcompetitionreview.com

cardiovascularbusiness.com

centerforbiosimilars.com

FTC sues drug middlemen for allegedly inflating insulin prices

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics